These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546 [Abstract] [Full Text] [Related]
3. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740 [Abstract] [Full Text] [Related]
4. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. Ann Thorac Surg; 2014 May; 97(5):1701-7. PubMed ID: 24679941 [Abstract] [Full Text] [Related]
5. Glucose Uptake Values in Positron Emission Tomography Are Useful to Predict Survival after Sublobar Resection for Lung Cancer. Nakamura H, Saji H, Marushima H, Tagaya R, Kimura H, Takagi M. Thorac Cardiovasc Surg; 2017 Mar; 65(2):150-157. PubMed ID: 26909560 [Abstract] [Full Text] [Related]
6. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879 [Abstract] [Full Text] [Related]
7. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678 [Abstract] [Full Text] [Related]
8. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma. Okada M, Nakayama H, Okumura S, Daisaki H, Adachi S, Yoshimura M, Miyata Y. J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1384-91. PubMed ID: 21440264 [Abstract] [Full Text] [Related]
9. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. Altorki NK, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, Sheppard B, Thurer R, Andaz S, Smith M, Mayfield W, Grannis F, Korst R, Pass H, Straznicka M, Flores R, Henschke CI, I-ELCAP Investigators. J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722 [Abstract] [Full Text] [Related]
10. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography. Tsutani Y, Nakayama H, Ito H, Handa Y, Mimae T, Miyata Y, Okada M. Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166 [Abstract] [Full Text] [Related]
11. Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography. Shiono S, Yanagawa N, Abiko M, Sato T. Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):637-43. PubMed ID: 24994703 [Abstract] [Full Text] [Related]
12. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S. J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323 [Abstract] [Full Text] [Related]
15. Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma. Uehara H, Tsutani Y, Okumura S, Nakayama H, Adachi S, Yoshimura M, Miyata Y, Okada M. Ann Thorac Surg; 2013 Dec; 96(6):1958-65. PubMed ID: 24021765 [Abstract] [Full Text] [Related]
16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [Abstract] [Full Text] [Related]
17. Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan. Hattori A, Suzuki K, Matsunaga T, Fukui M, Tsushima Y, Takamochi K, Oh S. Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):329-34. PubMed ID: 24351509 [Abstract] [Full Text] [Related]
18. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer. Kodama K, Higashiyama M, Okami J, Tokunaga T, Imamura F, Nakayama T, Inoue A, Kuriyama K. Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438 [Abstract] [Full Text] [Related]
19. Comparison of Segmentectomy and Lobectomy in Stage IA Adenocarcinomas. Zhao ZR, Situ DR, Lau RWH, Mok TSK, Chen GG, Underwood MJ, Ng CSH. J Thorac Oncol; 2017 May; 12(5):890-896. PubMed ID: 28111235 [Abstract] [Full Text] [Related]
20. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET. Yoshioka M, Ichiguchi O. Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220 [Abstract] [Full Text] [Related] Page: [Next] [New Search]